DINUTUXIMAB BETA for Metastatic lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where DINUTUXIMAB BETA was used for Metastatic lymphoma.
Most Reported Side Effects for DINUTUXIMAB BETA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 82 | 52.2% | 22 | 7 |
| Pyrexia | 57 | 36.3% | 2 | 7 |
| Pain | 46 | 29.3% | 3 | 3 |
| Death | 20 | 12.7% | 20 | 0 |
| Neoplasm progression | 20 | 12.7% | 14 | 0 |
| Device related bacteraemia | 17 | 10.8% | 0 | 0 |
| Device related infection | 16 | 10.2% | 0 | 0 |
| Diarrhoea | 11 | 7.0% | 1 | 1 |
| Therapy partial responder | 11 | 7.0% | 6 | 0 |
| Cough | 10 | 6.4% | 0 | 0 |
| Rash | 10 | 6.4% | 1 | 0 |
| Cholestasis | 7 | 4.5% | 0 | 7 |
| Pruritus | 7 | 4.5% | 1 | 0 |
| Acute myeloid leukaemia | 6 | 3.8% | 0 | 0 |
| Alanine aminotransferase abnormal | 6 | 3.8% | 0 | 0 |
Other Indications for DINUTUXIMAB BETA
Neuroblastoma (141)
Metastases to bone marrow (27)
Bone cancer metastatic (26)
Neuroblastoma recurrent (13)
Other Drugs Used for Metastatic lymphoma
CARBOPLATIN (18)
CYCLOPHOSPHAMIDE (12)
CISPLATIN (11)
ETOPOSIDE (11)
METHOTREXATE (11)
PEMBROLIZUMAB (11)
PACLITAXEL (10)
PALBOCICLIB (10)
DABRAFENIB (8)
GEMCITABINE (8)